These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 29746954)

  • 21. Latent Mycobacterium tuberculosis Infection and Interferon-Gamma Release Assays.
    Pai M; Behr M
    Microbiol Spectr; 2016 Oct; 4(5):. PubMed ID: 27763261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IFN-γ/TNF-α ratio in response to immuno proteomically identified human T-cell antigens of Mycobacterium tuberculosis - The most suitable surrogate biomarker for latent TB infection.
    Prabhavathi M; Pathakumari B; Raja A
    J Infect; 2015 Aug; 71(2):238-49. PubMed ID: 25936741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Key role of effector memory CD4+ T lymphocytes in a short-incubation heparin-binding hemagglutinin gamma interferon release assay for the detection of latent tuberculosis.
    Wyndham-Thomas C; Corbière V; Dirix V; Smits K; Domont F; Libin M; Loyens M; Locht C; Mascart F
    Clin Vaccine Immunol; 2014 Mar; 21(3):321-8. PubMed ID: 24391135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis.
    Machingaidze S; Wiysonge CS; Gonzalez-Angulo Y; Hatherill M; Moyo S; Hanekom W; Mahomed H
    Pediatr Infect Dis J; 2011 Aug; 30(8):694-700. PubMed ID: 21427627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-gamma release assay test characteristics depend upon the prevalence of active tuberculosis.
    Davidow AL
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1411-5. PubMed ID: 19861015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Latent Tuberculosis Infection Diagnosis among Household Contacts in a High Tuberculosis-Burden Area: a Comparison between Transcript Signature and Interferon Gamma Release Assay.
    Kaul S; Nair V; Birla S; Dhawan S; Rathore S; Khanna V; Lohiya S; Ali S; Mannan S; Rade K; Malhotra P; Gupta D; Khanna A; Mohmmed A
    Microbiol Spectr; 2022 Apr; 10(2):e0244521. PubMed ID: 35416716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberculin test versus interferon gamma release assay in pregnant women with household contacts of tuberculosis patients.
    Chalid MT; Puspawaty D; Tahir AM; Najdah H; Massi MN
    Int J Mycobacteriol; 2022; 11(4):364-370. PubMed ID: 36510919
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic performance of a cytokine and IFN-γ-induced chemokine mRNA assay after Mycobacterium tuberculosis-specific antigen stimulation in whole blood from infected individuals.
    Kim S; Lee H; Kim H; Kim Y; Cho JE; Jin H; Kim DY; Ha SJ; Kang YA; Cho SN; Lee H
    J Mol Diagn; 2015 Jan; 17(1):90-9. PubMed ID: 25528189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of two interferon-gamma release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB) in testing for latent tuberculosis infection among HIV-infected adults.
    Sultan B; Benn P; Mahungu T; Young M; Mercey D; Morris-Jones S; Miller RF
    Int J STD AIDS; 2013 Oct; 24(10):775-9. PubMed ID: 23970606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.
    Blount RJ; Tran MC; Everett CK; Cattamanchi A; Metcalfe JZ; Connor D; Miller CR; Grinsdale J; Higashi J; Nahid P
    BMC Public Health; 2016 Aug; 16(1):875. PubMed ID: 27558397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of resuscitation promoting factors to screen for tuberculosis infection in household-exposed children in The Gambia.
    van Loon W; Gomez MP; Jobe D; Franken KLMC; Ottenhoff THM; Coninx M; Kestens L; Sutherland JS; Kampmann B; Tientcheu LD
    BMC Infect Dis; 2020 Jul; 20(1):469. PubMed ID: 32615981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-Gamma Release Assay Combined with Renal Indicators to Reduce the False-Negativity of Latent Tuberculosis Infection in End-Stage Renal Disease with Hemodialysis Patients.
    Xuan X; Park H; Kang YJ; Jung M; Kim S; Park Y; Lee EJ; Kim YN; Park JY; Chang HK; Kim J; Lim J; Kim S
    Discov Med; 2024 May; 36(184):1002-1011. PubMed ID: 38798259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profile of interferon-gamma response to latency-associated and novel in vivo expressed antigens in a cohort of subjects recently exposed to Mycobacterium tuberculosis.
    Araujo LS; da Silva NBM; da Silva RJ; Leung JAM; Mello FCQ; Saad MHF
    Tuberculosis (Edinb); 2015 Dec; 95(6):751-757. PubMed ID: 26421415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study.
    Pullar ND; Steinum H; Bruun JN; Dyrhol-Riise AM
    BMC Infect Dis; 2014 Dec; 14():667. PubMed ID: 25515915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High IFN-γ Release and Impaired Capacity of Multi-Cytokine Secretion in IGRA Supernatants Are Associated with Active Tuberculosis.
    Carrère-Kremer S; Rubbo PA; Pisoni A; Bendriss S; Marin G; Peries M; Bolloré K; Terru D; Godreuil S; Bourdin A; Van de Perre P; Tuaillon E
    PLoS One; 2016; 11(9):e0162137. PubMed ID: 27603919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of T-cell interferon-gamma release assays for Mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis.
    Kobashi Y; Shimizu H; Ohue Y; Mouri K; Obase Y; Miyashita N; Oka M
    Lung; 2010 Aug; 188(4):283-7. PubMed ID: 20422203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving T-cell assays for diagnosis of latent TB infection: Confirmation of the potential role of testing Interleukin-2 release in Iranian patients.
    Mamishi S; Pourakbari B; Shams H; Marjani M; Mahmoudi S
    Allergol Immunopathol (Madr); 2016; 44(4):314-21. PubMed ID: 26786720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential Role for Mycobacterium tuberculosis Specific IL-2 and IFN-γ Responses in Discriminating between Latent Infection and Active Disease after Long-Term Stimulation.
    Sun Q; Wei W; Sha W
    PLoS One; 2016; 11(12):e0166501. PubMed ID: 28033330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of indeterminate IFN-γ release assay in screening for latent TB in inflammatory bowel diseases.
    Papay P; Eser A; Winkler S; Frantal S; Primas C; Miehsler W; Angelberger S; Novacek G; Mikulits A; Vogelsang H; Reinisch W
    Eur J Clin Invest; 2011 Oct; 41(10):1071-6. PubMed ID: 21413978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.